Leon Lachman, Ph.D.
Chairman Emeritus, Board of Directors; Outside Director to the Board; and founder of Lachman Consultants. During his more than 40 years’ experience in the pharmaceutical industry, he has been at the forefront in the shift from the trial and error approach of dosage form development to the scientific approach to dosage form design. He has been involved in improving the practices of quality control and in the development, interpretation and evaluation of the GMPs, GLPs, GCPs, as well as numerous other FDA regulations, guidelines, and guidances published by the FDA. Dr. Lachman has contributed to more than 70 publications, including textbooks, on the subjects of quality control, stability testing, sterilization, lyophilization, complexations, kinetics, statistical applications to pharmaceutical systems, and more. Additionally, he has a number of patents in the area of pharmaceutical testing and dosage form design, and has presented numerous lectures for various societies, associations, colleges of pharmacy, and to FDA chemists.